We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-7.45%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$549M
AUM Growth
-$91.5M
Cap. Flow
-$50.6M
Cap. Flow %
-9.22%
Top 10 Hldgs %
42.34%
Holding
105
New
18
Increased
27
Reduced
20
Closed
23

Top Buys

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$9.69M
2
CYTK icon
Cytokinetics
CYTK
+$7.79M
3
AMD icon
Advanced Micro Devices
AMD
+$5.25M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$4.87M
5
PMN icon
ProMIS Neurosciences
PMN
+$4.77M

Top Sells

Rank Stock Value
1
NICE icon
Nice
NICE
+$9.95M
2
NVMI
Nova
NVMI
+$8.21M
3
CAMT icon
Camtek
CAMT
+$6.75M
4
SAGE
Sage Therapeutics
SAGE
+$6.02M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$5.29M

Sector Composition

Rank Sector Weight
1 Healthcare 60.67%
2 Technology 7.83%
3 Consumer Discretionary 2.21%
4 Communication Services 0.83%
5 Materials 0.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
1
CALL
Teva Pharmaceuticals
TEVA
$40.8B
$51.1M 9.32%
5,013,800
-3,130,900
-38% -$29.2M
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$453B
$48.9M 8.91%
136,500
+10,500
+8% +$3.89M
SNY icon
3
Sanofi
SNY
$103B
$26.8M 4.88%
499,515
-30,000
-6% -$1.6M
AZN icon
4
AstraZeneca
AZN
$263B
$19.3M 3.52%
142,530
– –
NICE icon
5
CALL
Nice
NICE
$5.79B
$17.9M 3.25%
105,000
+90,000
+600% +$17.9M
JNJ icon
6
Johnson & Johnson
JNJ
$618B
$14.8M 2.69%
94,831
-25,000
-21% -$4.13M
MRK icon
7
Merck
MRK
$322B
$12.7M 2.32%
123,600
+3,000
+2% +$323K
AMZN icon
8
Amazon
AMZN
$2.92T
$12.1M 2.21%
95,300
-29,000
-23% -$3.89M
TSEM icon
9
Tower Semiconductor
TSEM
$24.8B
$11.5M 2.1%
469,574
+302,128
+180% +$9.69M
SNDX icon
10
Syndax Pharmaceuticals
SNDX
$1.69B
$11.2M 2.04%
773,061
+50,000
+7% +$946K
MSFT icon
11
Microsoft
MSFT
$3.45T
$10.9M 1.98%
34,442
+130
+0.4% +$43K
RARE icon
12
Ultragenyx Pharmaceutical
RARE
$2.45B
$9.24M 1.68%
259,135
+75,439
+41% +$2.99M
BBIO icon
13
BridgeBio Pharma
BBIO
$15.7B
$9.11M 1.66%
345,537
+23,902
+7% +$678K
NVO
14
Novo Nordisk
NVO
$208B
$8.46M 1.54%
93,080
-20,000
-18% -$1.76M
PRAX icon
15
Praxis Precision Medicines
PRAX
$8.58B
$8.29M 1.51%
323,354
-260,935
-45% -$4.94M
LLY icon
16
Eli Lilly
LLY
$1.02T
$7.62M 1.39%
14,190
-1,500
-10% -$773K
MDGL icon
17
Madrigal Pharmaceuticals
MDGL
$10.8B
$7.43M 1.35%
50,867
+25,867
+103% +$4.87M
SWTX
18
DELISTED
SpringWorks Therapeutics
SWTX
$7.4M 1.35%
319,911
+7,286
+2% +$199K
IMTX icon
19
Immatics
IMTX
$1.18B
$7.15M 1.3%
617,173
– –
SHLT
20
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
$6.96M 1.27%
632,256
-82,317
-12% -$789K
SEDG icon
21
CALL
SolarEdge
SEDG
$2.51B
$6.93M 1.26%
+53,500
New +$10.3M
CYTK icon
22
Cytokinetics
CYTK
$10.5B
$6.89M 1.26%
+233,933
New +$7.79M
ABBV icon
23
AbbVie
ABBV
$443B
$6.86M 1.25%
46,000
-10,000
-18% -$1.47M
PANW icon
24
Palo Alto Networks
PANW
$270B
$6.74M 1.23%
57,518
+3,518
+7% +$416K
BIIB icon
25
Biogen
BIIB
$30B
$6.64M 1.21%
25,846
+2,000
+8% +$535K
1
2 3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sphera Funds Management held 105 positions worth $549M, down 14% from $640M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sphera Funds Management withdrew a net $50.6M in Q3 2023, closing 23 positions and reducing 20 holdings. Its most notable exit was Nova, an estimated $8.21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Cytokinetics worth $6.89M.

  • Sphera Funds Management's largest Q3 2023 buy was Cytokinetics: 233,933 shares worth $6.89M.
  • Sphera Funds Management added most to Tower Semiconductor in Q3 2023, an estimated $9.69M increase.
  • Sphera Funds Management's biggest Q3 2023 reduction was Nice, cutting an estimated $9.95M.
  • Sphera Funds Management fully exited Nova in Q3 2023, selling an estimated $8.21M.
  • Sphera Funds Management's ten largest holdings make up 42% of its $549M portfolio in Q3 2023.
  • Sphera Funds Management opened 18 new positions and closed 23 in Q3 2023.
  • Sphera Funds Management's portfolio value fell 14% quarter-over-quarter to $549M.

Based on Sphera Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.